Regulation of mouse brain-selective sulfotransferase Sult4a1 by cAMP response element-binding protein and activating transcription factor-2

Molecular Pharmacology

Volumn 78, Issue 3, 2010, Pages 503-510

  Butcher, Neville J ^a   Mitchell, Deanne J ^a   Burow, Rachel ^a   Minchin, Rodney F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; BRAIN ENZYME; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MESSENGER RNA; MU OPIATE RECEPTOR; PROTEIN C JUN; SULFOTRANSFERASE; SULFOTRANSFERASE 4A1; UNCLASSIFIED DRUG; ATF2 PROTEIN, HUMAN; SULT4A1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BASE PAIRING; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; GENE DELETION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; ISOLATION PROCEDURE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REGULATORY SEQUENCE;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; MICE; REGULATORY SEQUENCES, NUCLEIC ACID; SULFOTRANSFERASES;

EID: 77956238414     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.063404     Document Type: Article

References (32)

1. Allali-Hassani A, Pan PW, Dombrovski L, Najmanovich R, Tempel W, Dong A, Loppnau P, Martin F, Thornton J, Thonton J, et al. (2007) Structural and chemical profiling of the human cytosolic sulfotransferases. PLoS Biol 5:e97.
2. Alnouti Y and Klaassen CD (2006) Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242-255. (Pubitemid 44400443)
3. Arumugam TV, Tang SC, Lathia JD, Cheng A, Mughal MR, Chigurupati S, Magnus T, Chan SL, Jo DG, Ouyang X, et al. (2007) Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci USA 104:14104-14109.
4. Benbrook DM and Jones NC (1990) Heterodimer formation between CREB and JUN proteins. Oncogene 5:295-302.
5. Bilecki W, Wawrzczak-Bargiela A, and Przewlocki R (2004) Activation of AP-1 and CRE-dependent gene expression via mu-opioid receptor. J Neurochem 90:874-882.
6. Butcher NJ, Arulpragasam A, Pope C, and Minchin RF (2003) Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1). Biochem J 376:441-448.
7. Carlezon WA Jr, Duman RS, and Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28:436-445.
8. Chakrabarti S, Law PY, and Loh HH (1995) Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine. Brain Res Mol Brain Res 30:269-278.
9. Falany CN, Xie X, Wang J, Ferrer J, and Falany JL (2000) Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain. Biochem J 346:857-864.
10. Foulkes NS and Sassone-Corsi P (1996) Transcription factors coupled to the cAMP-signalling pathway. Biochim Biophys Acta 1288:F101-F121.
11. Green TA, Alibhai IN, Unterberg S, Neve RL, Ghose S, Tamminga CA, and Nestler EJ (2008) Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. J Neurosci 28:2025-2032.
12. Gupta S, Campbell D, Dérijard B, and Davis RJ (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393.
13. Hai T and Curran T (1991) Cross-family dimerization of transcription factors Fos/ Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88:3720-3724.
14. Hildebrandt MA, Carrington DP, Thomae BA, Eckloff BW, Schaid DJ, Yee VC, Weinshilboum RM, and Wieben ED (2007) Genetic diversity and function in the human cytosolic sulfotransferases. Pharmacogenomics J 7:133-143.
15. Kara CJ, Liou HC, Ivashkiv LB, and Glimcher LH (1990) A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol Cell Biol 10:1347-1357.
16. Lewis AG and Minchin RF (2009) Lack of exonic sulfotransferase 4A1 mutations in controls and schizophrenia cases. Psychiatr Genet 19:53-55.
17. Ligeza A, Wawrzczak-Bargiela A, Kaminska D, Korostynski M, and Przewlocki R (2008) Regulation of ERK1/2 phosphorylation by acute and chronic morphine - implications for the role of cAMP-responsive element binding factor (CREB)-dependent and Ets-like protein-1 (Elk-1)-dependent transcription; small interfering RNA-based strategy. FEBS J 275:3836-3849.
18. Liyou NE, Buller KM, Tresillian MJ, Elvin CM, Scott HL, Dodd PR, Tannenberg AE, and McManus ME (2003) Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: an immunohistochemical study. J Histochem Cytochem 51:1655-1664.
19. Lonze BE and Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-623.
20. Mayr B and Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609.
21. McClung CA and Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3-17.
22. Minchin RF, Lewis A, Mitchell D, Kadlubar FF, and McManus ME (2008) Sulfotransferase 4A1. Int J Biochem Cell Biol 40:2686-2691.
23. Mitchell DJ and Minchin RF (2009) Cytosolic Aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1. Mol Pharmacol 76:388-395.
24. Ouwens DM, de Ruiter ND, van der Zon GC, Carter AP, Schouten J, van der Burgt C, Kooistra K, Bos JL, Maassen JA, and van Dam H (2002) Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J 21: 3782-3793.
25. Pittenger C and Duman RS (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88-109.
26. Quandt K, Frech K, Karas H, Wingender E, and Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884.
27. Reimold AM, Grusby MJ, Kosaras B, Fries JW, Mori R, Maniwa S, Clauss IM, Collins T, Sidman RL, Glimcher MJ, et al. (1996) Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379:262-265.
28. Thiel G, Al Sarraj J, Vinson C, Stefano L, and Bach K (2005) Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription. J Neurochem 92:321-336.
29. van Dam H and Castellazzi M (2001) Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20:2453-2464.
30. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, and Angel P (1995) ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14:1798-1811.
31. Verdecia MA, Bowman ME, Lu KP, Hunter T, and Noel JP (2000) Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat Struct Biol 7:639-643.
32. West AE, Griffith EC, and Greenberg ME (2002) Regulation of transcription factors by neuronal activity. Nat Rev Neurosci 3:921-931.